PROVIDER PROFILE · NPI 1922383751
Cindy Kennedy
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
6,831
Beneficiaries
—
Total drug cost
$8.9M
Distinct drugs
24
Brand share
96.3%
Top prescribed drugs
Apixaban2,569 claims
Rivaroxaban1,585 claims
Evolocumab1,449 claims
Empagliflozin327 claims
Alirocumab242 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE